Enliven Therapeutics (NASDAQ:ELVN) Shares Down 2.2% Following Insider Selling
Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) were down 2.2% during mid-day trading on Tuesday after an insider sold shares in the company. The company traded as low as $14.18 and last traded at $14.52. Approximately 20,237 shares traded hands during trading, a decline of 85% from the average daily volume of […]
More Stories
Enhancing Employee Experience: The Evolving Role of EOR Providers
In today’s globalised and fast-evolving workplace, businesses emphasise employee experience (EX) more intensely. Organisations that prioritise employee well-being, job satisfaction,...
Avantax Advisory Services Inc. Acquires 7,229 Shares of JPMorgan Chase & Co. (NYSE:JPM)
Avantax Advisory Services Inc. boosted its stake in shares of JPMorgan Chase & Co. (NYSE:JPM) by 2.3% during the fourth...
Parkworth Wealth Management Inc. Invests $102,000 in JPMorgan Chase & Co. (NYSE:JPM)
Parkworth Wealth Management Inc. acquired a new position in JPMorgan Chase & Co. (NYSE:JPM) in the 4th quarter, HoldingsChannel.com reports....
1,087 Shares in JPMorgan Chase & Co. (NYSE:JPM) Bought by Austin Wealth Management LLC
Austin Wealth Management LLC acquired a new position in shares of JPMorgan Chase & Co. (NYSE:JPM) in the fourth quarter,...
JPMorgan Chase & Co. (NYSE:JPM) Stake Increased by Great Lakes Advisors LLC
Great Lakes Advisors LLC increased its stake in JPMorgan Chase & Co. (NYSE:JPM) by 4.0% in the 4th quarter, Holdings...
10,614 Shares in JPMorgan Chase & Co. (NYSE:JPM) Purchased by SHEPHERD WEALTH MANAGEMENT Ltd LIABILITY Co
SHEPHERD WEALTH MANAGEMENT Ltd LIABILITY Co purchased a new position in JPMorgan Chase & Co. (NYSE:JPM – Free Report) in...